"By Kathleen Doheny
WebMD Health News
Reviewed by Michael W. Smith, MD
Dec. 30, 2013 -- The FDA has rejected the new multiple sclerosis drug Lemtrada, saying the drugmaker didn't show the drug's benefits outweigh some s"...
- Patient Information:
Details with Side Effects
Safety of doses higher than 0.25 mg every other day has not been adequately evaluated. The maximum amount of interferon beta-1b that can be safely administered has not been determined.
EXTAVIA (interferon beta-1b kit) is contraindicated in patients with a history of hypersensitivity to natural or recombinant interferon beta, Albumin (Human), USP, or any other component of the formulation.
Last reviewed on RxList: 9/16/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Extavia Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.